EXCERPT:
FAUCI: “The original data that was put forth it looked like the dose and the regimen for the children who were 6 months to 24 months worked well, but it turned out that the other dose, namely the other group, from 24 months to 4 years, did not yet reach the level of non-inferiority. So the studies are continued. It looks like it will be a 3-dose regimen. I don’t think we can predict when we will see an EUA with that because the company is still putting the data before the FDA and I certainly don’t want to get ahead of the FDA because I’m not privy to the data, and even if I were I wouldn’t want to anticipate what the FDA would do. I think we just need to be patient.”